| 1 | 10 mg | - | - | - | - | 0961件: 96 💬 | 
| 2 | 10 mg natura-alpha capsule | - | - | - | - | 0971件: 97 💬 | 
| 3 | 10 mg/kg cnto 136 | - | - | - | - | 0491件: 49 💬 | 
| 4 | 2 x 10 mg natura-alpha capsules | - | - | - | - | 0971件: 97 💬 | 
| 5 | [formistin 10 mg] | - | - | - | - | 0131件: 13 💬 | 
| 6 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | Clarithromycin | 3件: D00276D00276, D00278D00278, D00424D00424 💬 | - | - | 0961件: 96 💬 | 
| 7 | Acr16 10 mg | - | - | - | - | 0081件:  8  💬 | 
| 8 | Adderall xr 10 mg | - | - | - | - | 0131件: 13 💬 | 
| 9 | Amifampridine phosphate 10 mg oral tablet | Amifampridine | 1件: D10228D10228 💬 | KCNA44件: KCNA4, KCNC3, KCND2, KCND3 💬 | Cortisol synthesis and secretion4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia | 0031件:  3  💬 | 
| 10 | Aricept 10 mg | - | - | - | - | 0131件: 13 💬 | 
| 11 | Aricept 10 mg filmdragerade tabletter | - | - | - | - | 0131件: 13 💬 | 
| 12 | Atn-103 10 mg q4wks | - | - | - | - | 0461件: 46 💬 | 
| 13 | Atn-103 10 mg q8wks | - | - | - | - | 0461件: 46 💬 | 
| 14 | Azd9567 10 mg | - | - | - | - | 0461件: 46 💬 | 
| 15 | Baclofen er capsules (grs) 10 mg | Baclofen | 1件: D00241D00241 💬 | GABBR12件: GABBR1, GABBR2 💬 | Estrogen signaling pathway7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway | 0131件: 13 💬 | 
| 16 | Baclofen tablets usp 10 mg | Baclofen | 1件: D00241D00241 💬 | GABBR12件: GABBR1, GABBR2 💬 | Estrogen signaling pathway7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway | 0131件: 13 💬 | 
| 17 | Bardoxolone methyl 10 mg | Bardoxolone | 2件: D09584D09584, D09585D09585 💬 | - | - | 0671件: 67 💬 | 
| 18 | Belimumab 10 mg | Belimumab | 1件: D03068D03068 💬 | TNFSF13B1件: TNFSF13B 💬 | Cytokine-cytokine receptor interaction4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis | 2221件: 222 💬 | 
| 19 | Belimumab 10 mg/kg | Belimumab | 1件: D03068D03068 💬 | TNFSF13B1件: TNFSF13B 💬 | Cytokine-cytokine receptor interaction4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis | 0433件: 43, 46, 49 💬 | 
| 20 | Belimumab 10 mg/kg plus standard therapy | Belimumab | 1件: D03068D03068 💬 | TNFSF13B1件: TNFSF13B 💬 | Cytokine-cytokine receptor interaction4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis | 0491件: 49 💬 | 
| 21 | Bf 2.649 10 mg | - | - | - | - | 0061件:  6  💬 | 
| 22 | Bi 655066 10 mg/ml | - | - | - | - | 0961件: 96 💬 | 
| 23 | Brensocatib 10 mg | Brensocatib | - | - | - | 2991件: 299 💬 | 
| 24 | Cannabidiol tablet 10 mg | Cannabidiol | 1件: D10915D10915 💬 | CNR12件: CNR1, CNR2 💬 | Neuroactive ligand-receptor interaction4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis | 0462件: 46, 271 💬 | 
| 25 | Chronocort® 10 mg | - | - | - | - | 0811件: 81 💬 | 
| 26 | Cialis 10 mg film-coated tablets | - | - | - | - | 0862件: 86, 113 💬 | 
| 27 | Cp-690,550 10 mg | - | - | - | - | 0971件: 97 💬 | 
| 28 | Desmopressine nasal spray 10 mg/ml, flacon 60 doses | Desmopressin | 2件: D00291D00291, D02235D02235 💬 | AVPR22件: AVPR2, F8 💬 | Complement and coagulation cascades4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption | 2251件: 225 💬 | 
| 29 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg | Dextromethorphan | 7件: D00642D00642, D00643D00643, D00848D00848, D02272D02272, D03742D03742, D03744D03744, D08458D08458 💬 | GRIN111件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | Adrenergic signaling in cardiomyocytes22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway | 0022件:  2 , 13 💬 | 
| 30 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg | Dextromethorphan | 7件: D00642D00642, D00643D00643, D00848D00848, D02272D02272, D03742D03742, D03744D03744, D08458D08458 💬 | GRIN111件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | Adrenergic signaling in cardiomyocytes22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway | 0022件:  2 , 13 💬 | 
| 31 | E6011 10 mg/kg | - | - | - | - | 0961件: 96 💬 | 
| 32 | Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) | - | - | - | - | 0131件: 13 💬 | 
| 33 | Fampyra 10 mg prolonged-release tablets | - | - | - | - | 0131件: 13 💬 | 
| 34 | Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse | - | - | - | - | 0111件: 11 💬 | 
| 35 | Foliglurax 10 mg (treatment a) | Foliglurax | - | - | - | 0061件:  6  💬 | 
| 36 | Formistin - 10 mg compresse rivestite con film 20 compresse | - | - | - | - | 0131件: 13 💬 | 
| 37 | Formistin 10 mg | - | - | - | - | 0131件: 13 💬 | 
| 38 | Gwp42003-p 10 mg/kg/day dose | - | - | - | - | 1401件: 140 💬 | 
| 39 | Idursulfase it (10 mg) | Idursulfase | 1件: D04499D04499 💬 | IDS1件: IDS 💬 | Glycosaminoglycan degradation3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways | 0191件: 19 💬 | 
| 40 | Increlex 10 mg/ml | - | - | - | - | 0781件: 78 💬 | 
| 41 | Increlex 10 mg/ml, solución inyectable | - | - | - | - | 0781件: 78 💬 | 
| 42 | Infliximab 10 mg/kg | Infliximab | 1件: D02598D02598 💬 | TNF1件: TNF 💬 | AGE-RAGE signaling pathway in diabetic complications65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway | 0463件: 46, 96, 97 💬 | 
| 43 | Ins1007 10 mg oral tablet | - | - | - | - | 2991件: 299 💬 | 
| 44 | Ipx056 10 mg | - | - | - | - | 0131件: 13 💬 | 
| 45 | Ipx056-10 mg | - | - | - | - | 0131件: 13 💬 | 
| 46 | Isis 443139 10 mg | - | - | - | - | 0081件:  8  💬 | 
| 47 | Jnj-38518168 (10 mg) | - | - | - | - | 0461件: 46 💬 | 
| 48 | Jnj-38518168-zbq - film-coated tablet - 10 mg | - | - | - | - | 0461件: 46 💬 | 
| 49 | Jnj-39758979 (10 mg) | - | - | - | - | 0461件: 46 💬 | 
| 50 | Jnj-39758979-aac - enteric coated tablet - 10 mg | - | - | - | - | 0461件: 46 💬 | 
| 51 | Jnj-54781532-aad-10 mg | - | - | - | - | 0971件: 97 💬 | 
| 52 | Kn019, 10 mg/kg | - | - | - | - | 0461件: 46 💬 | 
| 53 | Lci699, 10 mg | - | - | - | - | 0751件: 75 💬 | 
| 54 | Letairis 10 mg | - | - | - | - | 0851件: 85 💬 | 
| 55 | Liposomal cyclosporine a 10 mg | Cyclosporine | 1件: D00184D00184 💬 | PPP3CA5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | Alzheimer disease32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway | 2281件: 228 💬 | 
| 56 | Lojuxta 10 mg hard capsules | - | - | - | - | 0791件: 79 💬 | 
| 57 | Mabcampath 10 mg/ml concentrado para solución para perfusión | - | - | - | - | 0131件: 13 💬 | 
| 58 | Mabthera 500 mg (10 mg/ml) concentrate for solution for infusion | - | - | - | - | 0461件: 46 💬 | 
| 59 | Macitentan 10 mg | Macitentan | 1件: D10135D10135 💬 | EDNRA2件: EDNRA, EDNRB 💬 | Calcium signaling pathway9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0513件: 51, 86, 88 💬 | 
| 60 | Macitentan 10 mg tablet, once daily. | Macitentan | 1件: D10135D10135 💬 | EDNRA2件: EDNRA, EDNRB 💬 | Calcium signaling pathway9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 61 | Mavenclad 10 mg tablets | - | - | - | - | 0131件: 13 💬 | 
| 62 | Mavenclad tabletter 10 mg | - | - | - | - | 0131件: 13 💬 | 
| 63 | Mavrilimumab 10 mg | Mavrilimumab | 1件: D09930D09930 💬 | CSF2RA1件: CSF2RA 💬 | Cytokine-cytokine receptor interaction4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer | 0461件: 46 💬 | 
| 64 | Mbx-8025 10 mg capsule | MBX-8025 | - | - | - | 0931件: 93 💬 | 
| 65 | Metex 10 mg/ml injektionslösung, fertigspritze | - | - | - | - | 0461件: 46 💬 | 
| 66 | Methotrexate 10 mg | Methotrexate | 2件: D00142D00142, D02115D02115 💬 | DHFR2件: DHFR, DHFR2 💬 | Antifolate resistance5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate | 0461件: 46 💬 | 
| 67 | Methotrexate 10 mg tablets | Methotrexate | 2件: D00142D00142, D02115D02115 💬 | DHFR2件: DHFR, DHFR2 💬 | Antifolate resistance5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate | 0461件: 46 💬 | 
| 68 | Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al | Metoclopramide | 3件: D00726D00726, D02213D02213, D05008D05008 💬 | DRD21件: DRD2 💬 | Alcoholism8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway | 0511件: 51 💬 | 
| 69 | Metoject 10 mg/ml | - | - | - | - | 0501件: 50 💬 | 
| 70 | Metoject 10 mg/ml, solution injectable en seringue pré-remplie | - | - | - | - | 0441件: 44 💬 | 
| 71 | Naproxen 10 mg/kg | Naproxen | 1件: D00118D00118 💬 | PTGS12件: PTGS1, PTGS2 💬 | Alzheimer disease23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway | 0461件: 46 💬 | 
| 72 | Nicotine nasal spray 10 mg/ml (0.5 mg/spray) | Nicotine | 3件: D03365D03365, D05156D05156, D05157D05157 💬 | CHRNA116件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | Alzheimer disease7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases | 0061件:  6  💬 | 
| 73 | Nitisinone 10 mg tablet high compritol | Nitisinone | 1件: D05177D05177 💬 | HPD1件: HPD 💬 | Biosynthesis of cofactors5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis | 2411件: 241 💬 | 
| 74 | Nnc0195-0092 10 mg/1.5 ml pds290-10 | - | - | - | - | 0781件: 78 💬 | 
| 75 | Nnc0195-0092 pds290 10 mg-1.5 ml | - | - | - | - | 0781件: 78 💬 | 
| 76 | Nnc0195-0092 pds290 10 mg/1.5 ml | - | - | - | - | 0781件: 78 💬 | 
| 77 | Norditropin flexpro 10 mg | - | - | - | - | 0781件: 78 💬 | 
| 78 | Norditropin flexpro 10 mg/1.5 ml | - | - | - | - | 0781件: 78 💬 | 
| 79 | Norditropin nordiflex® 10 mg/1.5 ml | - | - | - | - | 0781件: 78 💬 | 
| 80 | Norditropin simplexx 10 mg | - | - | - | - | 0781件: 78 💬 | 
| 81 | Nutropinaq 10 mg/2 ml | - | - | - | - | 0781件: 78 💬 | 
| 82 | Nutropinaq 10 mg/2 ml (30 ui) | - | - | - | - | 0781件: 78 💬 | 
| 83 | Nutropinaq 10 mg/2 ml (30 ui), solución inyectable | - | - | - | - | 0781件: 78 💬 | 
| 84 | Omaveloxolone capsules, 10 mg | Omaveloxolone | 1件: D10964D10964 💬 | NFE2L21件: NFE2L2 💬 | Fluid shear stress and atherosclerosis5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum | 0181件: 18 💬 | 
| 85 | Opsumit 10 mg tablet | - | - | - | - | 0511件: 51 💬 | 
| 86 | Oxn 10 mg / 5 mg pr | - | - | - | - | 0061件:  6  💬 | 
| 87 | Oxn 20 mg / 10 mg pr | - | - | - | - | 0061件:  6  💬 | 
| 88 | Oxn 20/10 mg pr | - | - | - | - | 2261件: 226 💬 | 
| 89 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 90 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 91 | Oxycodone/naloxone prolonged release tablets 20/10 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 92 | Palovarotene - 10 mg | Palovarotene | 1件: D09365D09365 💬 | - | - | 2721件: 272 💬 | 
| 93 | Pf-04171327 10 mg | - | - | - | - | 0461件: 46 💬 | 
| 94 | Pf-06651600 10 mg | PF-06651600 | - | - | - | 0971件: 97 💬 | 
| 95 | Plovamer acetate 10 mg | Acetate | - | - | - | 0131件: 13 💬 | 
| 96 | Ponesimod 10 mg | Ponesimod | 1件: D11215D11215 💬 | S1PR11件: S1PR1 💬 | FoxO signaling pathway3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway | 0131件: 13 💬 | 
| 97 | Preladenant 10 mg tablet | Preladenant | 1件: D09717D09717 💬 | ADORA2A1件: ADORA2A 💬 | Alcoholism7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway | 0061件:  6  💬 | 
| 98 | Remodulin® (treprostinil) 10 mg/ml solution for infusion | Treprostinil | 1件: D06213D06213 💬 | PTGIR1件: PTGIR 💬 | Neuroactive ligand-receptor interaction3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction | 0861件: 86 💬 | 
| 99 | Revatio 10 mg/ml powder for oral suspension | - | - | - | - | 0861件: 86 💬 | 
| 100 | Rhhns-10 mg | - | - | - | - | 0191件: 19 💬 | 
| 101 | Risankizumab 10 mg/ml | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0961件: 96 💬 | 
| 102 | Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml | Rituximab | 1件: D02994D02994 💬 | MS4A11件: MS4A1 💬 | Hematopoietic cell lineage1件: Hematopoietic cell lineage | 0131件: 13 💬 | 
| 103 | Rosuvastatin 10 mg | Rosuvastatin | 2件: D01915D01915, D08492D08492 💬 | HMGCR1件: HMGCR 💬 | AMPK signaling pathway4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis | 0961件: 96 💬 | 
| 104 | Sch 420814 10 mg | - | - | - | - | 0061件:  6  💬 | 
| 105 | Seladelpar 10 mg | - | - | - | - | 0931件: 93 💬 | 
| 106 | Seladelpar 10 mg capsule | - | - | - | - | 0931件: 93 💬 | 
| 107 | Seladelpar 5-10 mg | - | - | - | - | 0931件: 93 💬 | 
| 108 | Soliris - 300 mg concentrato per soluzione per infusione - uso endovenoso 1 flaconcino (vetro) 30 ml (10 mg/ml) | - | - | - | - | 1091件: 109 💬 | 
| 109 | Som230 lar 10 mg | - | - | - | - | 0751件: 75 💬 | 
| 110 | Somapacitan 10 mg/1.5ml pds290 | Somapacitan | 1件: D11194D11194 💬 | GHR1件: GHR 💬 | Cytokine-cytokine receptor interaction5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway | 0781件: 78 💬 | 
| 111 | Sortis 10 mg | - | - | - | - | 0931件: 93 💬 | 
| 112 | Sporanox 10 mg/ml oral solution | - | - | - | - | 2991件: 299 💬 | 
| 113 | Ta-650 10 mg/kg | - | - | - | - | 0461件: 46 💬 | 
| 114 | Targinact 10 mg/5 mg prolonged-release tablets | - | - | - | - | 0062件:  6 , 226 💬 | 
| 115 | Targinact 20 mg/10 mg prolonged-release tablets | - | - | - | - | 0061件:  6  💬 | 
| 116 | Targinact 20mg/10 mg prolonged-release tablets | - | - | - | - | 2261件: 226 💬 | 
| 117 | Tofacitinib 10 mg | Tofacitinib | 1件: D09970D09970 💬 | JAK14件: JAK1, JAK2, JAK3, TYK2 💬 | AGE-RAGE signaling pathway in diabetic complications35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | 2711件: 271 💬 | 
| 118 | Trimeton - 10 mg/1 ml soluzione iniettabile 5 fiale 1 ml | - | - | - | - | 0141件: 14 💬 | 
| 119 | Vitamin c 10mg/kg vitamin e 10 mg/kg | Ascorbic acid | 2件: D00018D00018, D02331D02331 💬 | - | - | 2061件: 206 💬 | 
| 120 | Vitamin k 10 mg | Phylloquinone | 1件: D00148D00148 💬 | - | - | 0962件: 96, 97 💬 | 
| 121 | Volibris 10 mg comprimidos recubiertos con película | - | - | - | - | 0861件: 86 💬 | 
| 122 | Warfarin 10 mg | Warfarin | 3件: D00564D00564, D01280D01280, D08682D08682 💬 | NQO12件: NQO1, VKORC1 💬 | Biosynthesis of cofactors6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis | 0962件: 96, 97 💬 | 
| 123 | Zomacton 10 mg/ml | - | - | - | - | 0781件: 78 💬 |